Table 2. Incidence of hematologic toxicities related to BTD regimen in each group (%).
Group 1 |
Group 2 |
|||
---|---|---|---|---|
Grade 1-2 | Grade 3-4 | Grade 1-2 | Grade 3-4 | |
Thrombocytopenia | 16 (38.1%) | 4 (9.5%) | 12 (40.0%) | 4 (13.3%) |
Anemia | 10 (23.8%) | 5 (11.9%) | 10 (30.0%) | 4 (13.3%) |
Neutropenia | 8 (19.0%) | 2 (4.8%) | 4 (13.3%) | 1 (3.3%) |